Macquarie Group’s Mustang Bio MBIO Stock Holding History

Macquarie Group’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-160	Closed	-$1K	–	1765
2024 Q4	$1K	Hold	160	–	–	﹤0.01%	1597
2024 Q3	$2K	Hold	160	–	–	﹤0.01%	1645
2024 Q2	$4K	Hold	160	–	–	﹤0.01%	1742
2024 Q1	$8K	Hold	160	–	–	﹤0.01%	1598
2023 Q4	$11K	Hold	160	–	–	﹤0.01%	1620
2023 Q3	$16K	Buy	+160	New	+$31.1K	﹤0.01%	1601
2023 Q2	–	Sell	-160	Closed	-$44K	–	1698
2023 Q1	$44K	Hold	160	–	–	﹤0.01%	1642
2022 Q4	$47K	Hold	160	–	–	﹤0.01%	1667
2022 Q3	$56K	Hold	160	–	–	﹤0.01%	1925
2022 Q2	$70K	Hold	160	–	–	﹤0.01%	1964
2022 Q1	$121	Hold	160	–	–	﹤0.01%	1903
2021 Q4	$199K	Hold	160	–	–	﹤0.01%	1765
2021 Q3	$323K	Hold	160	–	–	﹤0.01%	1730
2021 Q2	$398K	Hold	160	–	–	﹤0.01%	1715
2021 Q1	$398K	Hold	160	–	–	﹤0.01%	1567
2020 Q4	$454K	Hold	160	–	–	﹤0.01%	1466
2020 Q3	$378K	Hold	160	–	–	﹤0.01%	1471
2020 Q2	$382K	Hold	160	–	–	﹤0.01%	1405
2020 Q1	$322K	Hold	160	–	–	﹤0.01%	1359
2019 Q4	$490K	Hold	160	–	–	﹤0.01%	1402
2019 Q3	$391K	Hold	160	–	–	﹤0.01%	1423
2019 Q2	$442K	Buy	+160	New	+$457K	﹤0.01%	1377

Other funds holding MBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group's MBIO Position: Q1 2025 in Review

Macquarie Group sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 160 shares — an estimated $1K sold.

Macquarie Group first reported a position in MBIO in Q2 2019 and held it in 22 quarters. The position peaked at $490K in Q4 2019. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

Macquarie Group reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
Macquarie Group sold 160 Mustang Bio shares in Q1 2025, an estimated $1K.
Macquarie Group first reported a position in Mustang Bio in Q2 2019 and held it in 22 quarters.
Macquarie Group's Mustang Bio position peaked at $490K in Q4 2019.
16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on Macquarie Group's 13F filing for Q1 2025, filed 15 May 2025.